AUB ScholarWorks

Hand-foot syndrome with docetaxel: A five-case series

Show simple item record

dc.contributor.author Farhat M.H.
dc.contributor.author El-Saghir N.S.
dc.contributor.author Shamseddine A.I.
dc.contributor.editor
dc.date 2008
dc.date.accessioned 2017-10-05T15:37:32Z
dc.date.available 2017-10-05T15:37:32Z
dc.date.issued 2008
dc.identifier
dc.identifier.isbn
dc.identifier.issn 02564947
dc.identifier.uri http://hdl.handle.net/10938/15774
dc.description.abstract [No abstract available]
dc.format.extent
dc.format.extent Pages: (374-377)
dc.language English
dc.publisher RIYADH
dc.relation.ispartof Publication Name: Annals of Saudi Medicine; Publication Year: 2008; Volume: 28; no. 5; Pages: (374-377);
dc.relation.ispartofseries
dc.relation.uri
dc.source Scopus
dc.subject.other
dc.title Hand-foot syndrome with docetaxel: A five-case series
dc.type Article
dc.contributor.affiliation Farhat, M.H., Department of Internal Medicine, American University of Beirut Medical Center, PO Box 11-0236-E21, Raid El Solh, Beirut 11070720, Lebanon
dc.contributor.affiliation El-Saghir, N.S., Department of Internal Medicine, American University of Beirut Medical Center, PO Box 11-0236-E21, Raid El Solh, Beirut 11070720, Lebanon
dc.contributor.affiliation Shamseddine, A.I., Department of Hematology-Oncology, American University of Beirut, PO Box 11-0236-E21, Raid El Solh, Beirut 11070720, Lebanon
dc.contributor.authorAddress Farhat, M.H.; Department of Internal Medicine, American University of Beirut Medical Center, PO Box 11-0236-E21, Raid El Solh, Beirut 11070720, Lebanon; email: bellanotchi@hotmail.com
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Internal Medicine;
dc.contributor.authorDepartment Internal Medicine
dc.contributor.authorDivision
dc.contributor.authorEmail bellanotchi@hotmail.com
dc.contributor.faculty Faculty of Medicine
dc.contributor.authorInitials Farhat, MH
dc.contributor.authorInitials El-Saghir, NS
dc.contributor.authorInitials Shamseddine, AI
dc.contributor.authorOrcidID
dc.contributor.authorReprintAddress Farhat, MH (reprint author), Amer Univ Beirut, Med Ctr, Dept Internal Med, POB 11-0236-E21, Beirut 11070720, Lebanon.
dc.contributor.authorResearcherID
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited Abushullaih S, 2002, CANCER INVEST, V20, P3, DOI 10.1081-CNV-120000360; Asgari MM, 1999, J CUTAN PATHOL, V26, P287, DOI 10.1111-j.1600-0560.1999.tb01846.x; BARDIA A, 2006, J CLIN ONCOL, V24, P184; Chu CY, 2000, BRIT J DERMATOL, V142, P808, DOI 10.1046-j.1365-2133.2000.03432.x; Crawford JH, 2002, EUR J HAEMATOL, V69, P315, DOI 10.1034-j.1600-0609.2002.02834.x; D'Agostino G, 2003, BRIT J CANCER, V89, P1180, DOI 10.1038-sj.bjc.6601284; Eich D, 2002, AM J CLIN ONCOL-CANC, V25, P599, DOI 10.1097-00000421-200212000-00015; Feizy Vida, 2003, Dermatol Online J, V9, P14; GORDON KB, 1995, CANCER, V75, P2169, DOI 10.1002-1097-0142(19950415)75:82169::AID-CNCR28207508223.0.CO;2-H; Gressett Sarah M, 2006, J Oncol Pharm Pract, V12, P131, DOI 10.1177-1078155206069242; Hui YF, 2000, PHARMACOTHERAPY, V20, P1221, DOI 10.1592-phco.20.15.1221.34593; Kara IG, 2006, BREAST, V15, P414, DOI 10.1016-j.breast.2005.07.007; Katoh M, 2004, J DERMATOL, V31, P403; Laack E, 2001, ANN ONCOL, V12, P1761, DOI 10.1023-A:1013575816870; Lin E, 2002, ONCOLOGY-NY, V16, P31; LIN EH, 2002, P AM SOC CLIN ONCOL, V21; Lopez AM, 1999, CANCER CHEMOTH PHARM, V44, P303, DOI 10.1007-s002800050981; Mrozek E, 2006, CLIN BREAST CANCER, V7, P141, DOI 10.3816-CBC.2006.n.023; Nagore E, 2000, Am J Clin Dermatol, V1, P225, DOI 10.2165-00128071-200001040-00004; O'Brien MER, 2004, ANN ONCOL, V15, P440, DOI 10.1093-annone-mdh097; PORTAL I, 1994, CANCER CHEMOTH PHARM, V34, P181, DOI 10.1007-BF00685939; Razis E, 2006, CANCER INVEST, V24, P514, DOI 10.1080-07357900600814847; Saif MW, 2006, CLIN COLORECTAL CANC, V6, P219, DOI 10.3816-CCC.2006.n.039; SCHEITHAUER W, 2004, ONCOLOGY WILLISTON P, V18, P1173; SCHEITHAUER W, 2004, ONCOLOGY WILLISTON P, V18, P1181; Scheithauer W, 2004, ONCOLOGY-NY, V18, P1161; Schrijvers D, 2000, BRIT J DERMATOL, V142, P1069, DOI 10.1046-j.1365-2133.2000.03518.x; Scotte F, 2005, J CLIN ONCOL, V23, P4424, DOI 10.1200-JCO.2005.15.651; SILVER FS, 1983, ANN INTERN MED, V98, P675; Vail DM, 1998, CLIN CANCER RES, V4, P1567; VUKELJA SJ, 1993, J NATL CANCER I, V85, P1432, DOI 10.1093-jnci-85.17.1432; Wilkes Gail M, 2005, Clin J Oncol Nurs, V9, P103; ZIMMERMAN GC, 1995, ARCH DERMATOL, V131, P202, DOI 10.1001-archderm.131.2.202; ZIMMERMAN GC, 1994, J NATL CANCER I, V86, P557, DOI 10.1093-jnci-86.7.557; ZUEHLKE RL, 1974, DERMATOLOGICA, V148, P90
dc.description.citedCount 4
dc.description.citedTotWOSCount 2
dc.description.citedWOSCount 2
dc.format.extentCount 4
dc.identifier.articleNo
dc.identifier.coden ANSME
dc.identifier.pubmedID
dc.identifier.scopusID 58249091942
dc.identifier.url
dc.publisher.address PUBLICATIONS OFFICE PO BOX 3354, RIYADH 11211, SAUDI ARABIA
dc.relation.ispartofConference
dc.relation.ispartofConferenceCode
dc.relation.ispartofConferenceDate
dc.relation.ispartofConferenceHosting
dc.relation.ispartofConferenceLoc
dc.relation.ispartofConferenceSponsor
dc.relation.ispartofConferenceTitle
dc.relation.ispartofFundingAgency
dc.relation.ispartOfISOAbbr Ann. Saudi Med.
dc.relation.ispartOfIssue 5
dc.relation.ispartOfPart
dc.relation.ispartofPubTitle Annals of Saudi Medicine
dc.relation.ispartofPubTitleAbbr Ann. Saudi Med.
dc.relation.ispartOfSpecialIssue
dc.relation.ispartOfSuppl
dc.relation.ispartOfVolume 28
dc.source.ID WOS:000261007000009
dc.type.publication Journal
dc.subject.otherAuthKeyword
dc.subject.otherChemCAS cyclophosphamide, 50-18-0
dc.subject.otherChemCAS docetaxel, 114977-28-5
dc.subject.otherChemCAS doxorubicin, 23214-92-8, 25316-40-9
dc.subject.otherChemCAS epirubicin, 56390-09-1, 56420-45-2
dc.subject.otherChemCAS fluorouracil, 51-21-8
dc.subject.otherChemCAS letrozole, 112809-51-5
dc.subject.otherChemCAS paclitaxel, 33069-62-4
dc.subject.otherChemCAS recombinant granulocyte colony stimulating factor, 121181-53-1
dc.subject.otherIndex cyclophosphamide
dc.subject.otherIndex docetaxel
dc.subject.otherIndex doxorubicin
dc.subject.otherIndex emollient agent
dc.subject.otherIndex epirubicin
dc.subject.otherIndex fluorouracil
dc.subject.otherIndex letrozole
dc.subject.otherIndex paclitaxel
dc.subject.otherIndex recombinant granulocyte colony stimulating factor
dc.subject.otherIndex steroid
dc.subject.otherIndex adjuvant therapy
dc.subject.otherIndex adult
dc.subject.otherIndex aged
dc.subject.otherIndex article
dc.subject.otherIndex breast cancer
dc.subject.otherIndex cancer adjuvant therapy
dc.subject.otherIndex clinical article
dc.subject.otherIndex drug substitution
dc.subject.otherIndex drug withdrawal
dc.subject.otherIndex female
dc.subject.otherIndex hand foot syndrome
dc.subject.otherIndex human
dc.subject.otherIndex mastectomy
dc.subject.otherIndex monotherapy
dc.subject.otherIndex multiple cycle treatment
dc.subject.otherIndex priority journal
dc.subject.otherIndex skin biopsy
dc.subject.otherIndex treatment refusal
dc.subject.otherKeywordPlus PALMAR-PLANTAR ERYTHRODYSESTHESIA
dc.subject.otherKeywordPlus METASTATIC BREAST-CANCER
dc.subject.otherKeywordPlus LIPOSOMAL DOXORUBICIN
dc.subject.otherKeywordPlus CUTANEOUS TOXICITY
dc.subject.otherKeywordPlus ACRAL ERYTHEMA
dc.subject.otherKeywordPlus PHASE-II
dc.subject.otherKeywordPlus CAPECITABINE
dc.subject.otherKeywordPlus THERAPY
dc.subject.otherKeywordPlus GEMCITABINE
dc.subject.otherKeywordPlus PYRIDOXINE
dc.subject.otherWOS Medicine, General and Internal


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


Browse

My Account